Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ASOPRISNIL
(3)
Small molecule
Progesterone receptor modulator
Unknown
Investigational
Unknown
ASOPRISNIL
×
Maximum Phase:
3
First Approval:
None
UNII:
72W09924WP
Molecule Type:
Small molecule
Molecular Formula:
C28H35NO4
Molecular Weight:
449.59
AlogP:
5.43
PSA:
68.12
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DINACICLIB
(3)
Small molecule
Cyclin-dependent kinase 1 inhibitor
Unknown
Investigational
Unknown
DINACICLIB
×
Maximum Phase:
3
First Approval:
None
UNII:
4V8ECV0NBQ
Molecule Type:
Small molecule
Molecular Formula:
C21H28N6O2
Molecular Weight:
396.5
AlogP:
2.28
PSA:
92.63
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NARLAPREVIR
(3)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Investigational
Unknown
NARLAPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
2857LA2O07
Molecule Type:
Small molecule
Molecular Formula:
C36H61N5O7S
Molecular Weight:
707.98
AlogP:
3.62
PSA:
170.85
HBD:
4.0
HBA:
#RotB:
13.0
Source:
ZOSUQUIDAR
(3)
Small molecule
P-glycoprotein 1 inhibitor
Unknown
Investigational
Unknown
ZOSUQUIDAR
×
Maximum Phase:
3
First Approval:
None
UNII:
AB5K82X98Y
Molecule Type:
Small molecule
Molecular Formula:
C32H31F2N3O2
Molecular Weight:
527.62
AlogP:
5.21
PSA:
48.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BIGUANIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BIGUANIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
FB4Q52I9K2
Molecule Type:
Small molecule
Molecular Formula:
C2H7N5
Molecular Weight:
101.11
AlogP:
-1.64
PSA:
111.77
HBD:
5.0
HBA:
#RotB:
0.0
Source:
DAPACONAZOLE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
DAPACONAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
H2976538CX
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2F3N2O
Molecular Weight:
415.24
AlogP:
6.17
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
BLONANSERIN
(3)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Approved
Unknown
BLONANSERIN
×
Maximum Phase:
3
First Approval:
None
UNII:
AQ316B4F8C
Molecule Type:
Small molecule
Molecular Formula:
C23H30FN3
Molecular Weight:
367.51
AlogP:
4.69
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ARGININE GLUTAMATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARGININE GLUTAMATE
×
Maximum Phase:
3
First Approval:
None
UNII:
TU1X77K34Q
Molecule Type:
Small molecule
Molecular Formula:
C11H23N5O6
Molecular Weight:
321.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
L-CITRULLINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
L-CITRULLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
29VT07BGDA
Molecule Type:
Small molecule
Molecular Formula:
C6H13N3O3
Molecular Weight:
175.19
AlogP:
-1.15
PSA:
118.44
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PIPAMPERONE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PIPAMPERONE
×
Maximum Phase:
3
First Approval:
None
UNII:
5402501F0W
Molecule Type:
Small molecule
Molecular Formula:
C21H30FN3O2
Molecular Weight:
375.49
AlogP:
2.59
PSA:
66.64
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PIRTOBRUTINIB
(3)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Approved
Unknown
PIRTOBRUTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
JNA39I7ZVB
Molecule Type:
Small molecule
Molecular Formula:
C22H21F4N5O3
Molecular Weight:
479.43
AlogP:
3.43
PSA:
125.26
HBD:
3.0
HBA:
#RotB:
7.0
Source:
ALIZAPRIDE
(3)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Investigational
Unknown
ALIZAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
P55703ZRZY
Molecule Type:
Small molecule
Molecular Formula:
C16H21N5O2
Molecular Weight:
315.38
AlogP:
1.35
PSA:
83.14
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BICIFADINE
(3)
Small molecule
Monoamine transporter inhibitor
Unknown
Investigational
Unknown
BICIFADINE
×
Maximum Phase:
3
First Approval:
None
UNII:
B0SV3N7J3H
Molecule Type:
Small molecule
Molecular Formula:
C12H15N
Molecular Weight:
173.26
AlogP:
1.86
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SELATOGREL
(3)
Small molecule
Purinergic receptor P2Y12 antagonist
Unknown
Investigational
Unknown
SELATOGREL
×
Maximum Phase:
3
First Approval:
None
UNII:
6DPK7O4PR7
Molecule Type:
Small molecule
Molecular Formula:
C28H39N6O8P
Molecular Weight:
618.63
AlogP:
1.73
PSA:
174.73
HBD:
3.0
HBA:
#RotB:
11.0
Source:
IMLUNESTRANT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
IMLUNESTRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADMILPARANT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ADMILPARANT
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06651600
(3)
Small molecule
TEC family kinase inhibitor
Unknown
Investigational
Unknown
PF-06651600
×
Maximum Phase:
3
First Approval:
None
UNII:
2OYE00PC25
Molecule Type:
Small molecule
Molecular Formula:
C15H19N5O
Molecular Weight:
285.35
AlogP:
1.94
PSA:
73.91
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CILEXETIL
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CILEXETIL
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C10H18O3
Molecular Weight:
186.25
AlogP:
2.88
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CEFTOBIPROLE MEDOCARIL
(3)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Investigational
Unknown
CEFTOBIPROLE MEDOCARIL
×
Maximum Phase:
3
First Approval:
None
UNII:
N99027V28J
Molecule Type:
Small molecule
Molecular Formula:
C26H26N8O11S2
Molecular Weight:
690.67
AlogP:
-0.54
PSA:
264.3
HBD:
4.0
HBA:
#RotB:
8.0
Source:
DAPRODUSTAT
(3)
Small molecule
Hypoxia-inducible factor prolyl hydroxylase inhibitor
Unknown
Approved
Unknown
DAPRODUSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
JVR38ZM64B
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O6
Molecular Weight:
393.44
AlogP:
1.26
PSA:
124.09
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BITOPERTIN
(3)
Small molecule
Glycine transporter 1 inhibitor
Unknown
Investigational
Unknown
BITOPERTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Q8L6AN59YY
Molecule Type:
Small molecule
Molecular Formula:
C21H20F7N3O4S
Molecular Weight:
543.46
AlogP:
3.94
PSA:
79.81
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RETOSIBAN
(3)
Small molecule
Oxytocin receptor antagonist
Unknown
Investigational
Unknown
RETOSIBAN
×
Maximum Phase:
3
First Approval:
None
UNII:
GIE06H28OX
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O5
Molecular Weight:
494.59
AlogP:
2.04
PSA:
104.98
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CENTANAFADINE HYDROCHLORIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CENTANAFADINE HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
265DN9X85W
Molecule Type:
Small molecule
Molecular Formula:
C15H16ClN
Molecular Weight:
245.75
AlogP:
2.7
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FILIBUVIR
(3)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
FILIBUVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
198J479Y2L
Molecule Type:
Small molecule
Molecular Formula:
C29H37N5O3
Molecular Weight:
503.65
AlogP:
5.12
PSA:
102.5
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TROFINETIDE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
TROFINETIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
Z2ME8F52QL
Molecule Type:
Small molecule
Molecular Formula:
C13H21N3O6
Molecular Weight:
315.33
AlogP:
-1.24
PSA:
150.03
HBD:
4.0
HBA:
#RotB:
7.0
Source:
GIREDESTRANT
(3)
Small molecule
Estrogen receptor alpha degrader
Unknown
Investigational
Unknown
GIREDESTRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
28P3DU6DB3
Molecule Type:
Small molecule
Molecular Formula:
C27H31F5N4O
Molecular Weight:
522.56
AlogP:
4.87
PSA:
54.53
HBD:
3.0
HBA:
#RotB:
9.0
Source:
AMRUBICIN HYDROCHLORIDE
(3)
Small molecule
DNA topoisomerase II alpha inhibitor
Unknown
Investigational
Unknown
AMRUBICIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
EUL6MP8FZW
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClNO9
Molecular Weight:
519.93
AlogP:
0.63
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
IDAZOXAN
(3)
Small molecule
Adrenergic receptor alpha-2 antagonist
Unknown
Investigational
Unknown
IDAZOXAN
×
Maximum Phase:
3
First Approval:
None
UNII:
Y310PA316B
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
0.83
PSA:
42.85
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ANTIMONY CATION (5+)
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ANTIMONY CATION (5+)
×
Maximum Phase:
3
First Approval:
None
UNII:
841L03HG64
Molecule Type:
Small molecule
Molecular Formula:
Sb+5
Molecular Weight:
121.76
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIPTOLIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIPTOLIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
19ALD1S53J
Molecule Type:
Small molecule
Molecular Formula:
C20H24O6
Molecular Weight:
360.41
AlogP:
1.1
PSA:
84.12
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BRILAROXAZINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
BRILAROXAZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZICRONAPINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ZICRONAPINE
×
Maximum Phase:
3
First Approval:
None
UNII:
QZV11V7G6A
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClN2
Molecular Weight:
354.93
AlogP:
4.94
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CLAMOXYQUIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
CLAMOXYQUIN
×
Maximum Phase:
3
First Approval:
None
UNII:
JUN13FZ6RF
Molecule Type:
Small molecule
Molecular Formula:
C17H24ClN3O
Molecular Weight:
321.85
AlogP:
3.42
PSA:
48.39
HBD:
2.0
HBA:
#RotB:
8.0
Source:
OMBRABULIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
OMBRABULIN
×
Maximum Phase:
3
First Approval:
None
UNII:
82JB1524Q6
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O6
Molecular Weight:
402.45
AlogP:
2.15
PSA:
112.27
HBD:
3.0
HBA:
#RotB:
9.0
Source:
OXOMEMAZINE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
OXOMEMAZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Q824SGH3RN
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2O2S
Molecular Weight:
330.45
AlogP:
3.17
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
GABOXADOL
(3)
Small molecule
GABA-A receptor; agonist GABA site agonist
Unknown
Investigational
Unknown
GABOXADOL
×
Maximum Phase:
3
First Approval:
None
UNII:
K1M5RVL18S
Molecule Type:
Small molecule
Molecular Formula:
C6H8N2O2
Molecular Weight:
140.14
AlogP:
0.03
PSA:
58.29
HBD:
2.0
HBA:
#RotB:
0.0
Source:
1
2
…
194
195
196
197
198
199
200
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA